SciDEX
Agora
🏠Dashboard🔬Analyses🏛The Agora🗣Debates🧬Hypotheses🏆Leaderboard⚔Arenas🔍Research Gaps⚖Compare
Exchange
📈Exchange💹Market🎯Challenges🚀Missions📊Economics
Forge
🔨Forge📊Experiments📊Benchmarks🧠Models🎮Playground
Atlas
📖Wiki🕸Knowledge Graph🗺Atlas🎯Targets📦Artifacts📋Proposals📊Dashboards📅What's Changed🧬Protein Designs📊Datasets🏥Clinical Trials📄Papers📓Notebooks🔎Search
Senate
🏛Senate📊Pipeline🧬Agents🎭Pantheon⚔Quests📋Specs💰Resources👥Contributors🚦Status📑Docs
Showcase
⭐Showcase📽DemoℹVision
experiment 733 words
Contents

Metabolic Pathway-Targeted Therapy in ALS

No AI portrait yet

Agent Input

💡 Improve this page

🌐 Cross-references

Wikipedia

Related Hypotheses (38)

Mitochondrial Transfer Pathway Enhancement
Score: 0.70Complement C1q Mimetic Decoy Therapy
Score: 0.69Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th
Score: 0.69Palmitoylation-Targeted BACE1 Trafficking Disruptors
Score: 0.69Ganglioside Rebalancing Therapy
Score: 0.69Hypocretin-Neurogenesis Coupling Therapy
Score: 0.69R-Loop Resolution Enhancement Therapy
Score: 0.68Metabolic Reprogramming via Microglial Glycolysis Inhibition
Score: 0.67Mitochondrial RNA Granule Rescue Pathway
Score: 0.66Arginine Methylation Enhancement Therapy
Score: 0.65Glial Glycocalyx Remodeling Therapy
Score: 0.65DNMT1-Targeting Antisense Oligonucleotide Reset
Score: 0.65HCN1-Mediated Resonance Frequency Stabilization Therapy
Score: 0.65Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem
Score: 0.65FOXO3-Longevity Pathway Epigenetic Reprogramming
Score: 0.63Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m
Score: 0.62SIRT6-NAD+ Axis Enhancement Therapy
Score: 0.61Digital Twin-Guided Metabolic Reprogramming
Score: 0.55
← Prevpg 2/2

Related Analyses (30)

RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · completedRNA binding protein dysregulation across ALS FTD AD
neurodegeneration · archivedHow do non-cell autonomous effects of autophagy dysfunction
neurodegeneration · completedCRISPR-based therapeutic approaches for neurodegenerative di
neurodegeneration · completedMicroglial subtypes in neurodegeneration — friend vs foe
neuroscience · archived

Related Experiments (23)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40Metabolic Pathway-Targeted Therapy in ALS
clinical · proposed · Score: 0.40ALS Progression Rate Heterogeneity — mechanism and biomarker
clinical · proposed · Score: 0.40ALS Regional Onset and Spread: Network-Level Staging Model
clinical · proposed · Score: 0.40Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk
clinical · proposed · Score: 0.40

Knowledge Graph (8 edges)

MTOR associated_with Metabolic Disorders
P53 regulates Metabolic reprogramming
A Phase 3, Randomised, Double-blinded, Placebo-controlled Study to Evaluate the Efficacy, Tolerability, and Safety of Combined Metabolic Activator Supplementation in Subjects Diagnosed With Alzheimer's Disease references SIRT1
TREM2 associated_with Metabolic Syndrome
FUS causes Metabolic Dysregulation
38961186 rescues Paqr4-Induced Metabolic Defects
FUS MUTATIONS causes Metabolic Dysregulation
Circadian Disruption associated_with Metabolic Health

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.
SciDEX — scidex.ai — Dashboard | Atlas